0005

COM:SAMIL-PHARM

삼일제약

  • Stock

Last Close

15,900.00

25/09 06:30

Market Cap

169.82B

Beta: -

Volume Today

694.45K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
7.93B
-
-11.19B
241.10%
588.37M
105.26%
886.60M
50.69%
-1.27B
242.86%
-8.56B
576.06%
786.26M
109.18%
1.34B
70.50%
-5.35B
498.84%
-28.29M
99.47%
1.66B
5,980.93%
depreciation and amortization
3.53B
-
3.41B
3.29%
3.04B
10.93%
3.15B
3.52%
3.64B
15.77%
3.69B
1.19%
4.02B
8.95%
4.20B
4.58%
4.71B
12.20%
4.99B
5.88%
5.37B
7.60%
deferred income tax
stock based compensation
change in working capital
-7.80B
-
-3.87B
50.34%
-4.66B
20.23%
-3.61B
22.37%
-3.01B
16.70%
-3.74B
24.13%
-1.46B
60.84%
-7.28B
397.84%
-5.19B
28.76%
-9.65B
85.97%
-766.85M
92.05%
accounts receivables
-2.51B
-
-4.52B
80.25%
-1.15B
74.52%
-4.11B
256.90%
-410.12M
90.02%
inventory
-183.07M
-
-214.33M
17.08%
53.91M
125.15%
1.92B
3,458.07%
-6.43B
435.18%
-8.65B
34.52%
551.41M
106.38%
-2.94B
633.93%
-181.39M
93.84%
-644.11M
255.09%
-7.91B
1,128.67%
accounts payables
-122.48M
-
1.68B
1,468.05%
-2.28B
235.95%
5.13B
325.27%
7.29B
42.16%
other working capital
-7.61B
-
-3.66B
51.96%
-4.71B
28.75%
-5.53B
17.47%
3.42B
161.82%
4.91B
43.66%
615.26M
87.48%
-1.50B
343.08%
-1.58B
5.52%
-10.03B
535.38%
262.23M
102.61%
other non cash items
-7.65B
-
-274.57M
96.41%
3.95B
1,537.68%
5.21B
32.11%
4.43B
15.14%
5.99B
35.39%
7.25B
21.03%
9.52B
31.26%
7.24B
23.93%
8.84B
22.13%
-2.07B
123.39%
net cash provided by operating activities
-3.99B
-
-11.92B
198.82%
2.92B
124.49%
5.63B
92.96%
3.79B
32.71%
-2.62B
169.14%
10.59B
503.96%
7.77B
26.59%
1.42B
81.78%
4.15B
193.18%
4.20B
1.02%
investments in property plant and equipment
-1.88B
-
-5.78B
207.31%
-2.54B
56.15%
-4.45B
75.57%
-43.34B
873.37%
-3.92B
90.96%
-14.48B
269.78%
-17.21B
18.85%
-33.09B
92.26%
-48.66B
47.04%
-24.39B
49.87%
acquisitions net
19.12B
-
231.54M
98.79%
514.13M
-
-6.92B
1,446.21%
-188.03M
-
169.44M
190.11%
822.96M
385.71%
272.79M
66.85%
5.21B
1,810.85%
purchases of investments
2.65B
-
-13.40B
606.22%
-4B
-
-2.05B
48.65%
-9.07B
341.56%
-13.15B
44.98%
-26.34B
100.35%
-10.31B
60.87%
-272.79M
97.35%
-860M
215.26%
sales maturities of investments
139M
-
1.57B
1,027.45%
10.24B
553.50%
5.00B
51.15%
8.14B
62.65%
8.94B
-
38.16B
326.82%
508.10M
98.67%
11.26B
2,116.40%
1
100.00%
other investing activites
183.91M
-
-83.57M
145.44%
1.84B
2,302.51%
78.19M
95.75%
6.68B
8,442.36%
-1.78B
126.65%
-7.17B
303.02%
638.22M
108.90%
-3.24B
607.70%
1.46B
145.02%
236.67M
83.78%
net cash used for investing activites
20.21B
-
-17.47B
186.47%
9.55B
154.64%
-2.86B
129.94%
-37.50B
1,212.20%
-14.77B
60.62%
-26.05B
76.43%
-4.59B
82.39%
-45.31B
887.32%
-35.94B
20.68%
-19.80B
44.90%
debt repayment
-15B
-
-10B
33.33%
-27.40B
174%
-12B
56.20%
-13.70B
14.17%
-10.99B
19.77%
-22.19B
101.90%
-20.51B
7.60%
-3.78B
81.56%
-43.49B
1,050.50%
-16.82B
61.33%
common stock issued
18.69B
-
16.97B
-
426.30K
100.00%
39.09B
-
common stock repurchased
-687.31M
-
52.30B
-
-1.99B
103.81%
-2.49B
25.03%
-30.18M
-
dividends paid
-782.03M
-
-782.03M
0%
-1.02B
30.52%
-1.02B
0%
-765.53M
25%
-765.53M
0%
-610.35M
20.27%
-918.89M
50.55%
-938.64M
2.15%
-1.00B
6.66%
other financing activites
9.65B
-
100.00M
98.96%
18.08B
17,981.09%
12.89B
28.72%
43.00B
233.61%
14.24B
66.89%
-439.29M
103.09%
20.09B
4,674.36%
10
100.00%
74.20B
742,001,617,300%
-734.40M
100.99%
net cash used provided by financing activities
-6.14B
-
7.32B
219.24%
-10.34B
241.34%
-132.22M
98.72%
28.53B
21,679.32%
19.45B
31.82%
29.06B
49.41%
-3.32B
111.43%
31.87B
1,059.17%
29.71B
6.80%
16.06B
45.95%
effect of forex changes on cash
-112.20M
-
-1.71K
-
112.30M
6,567,351.46%
290
100.00%
-67.44M
23,254,237.93%
126.69M
287.87%
-583.99M
560.94%
11.66M
102.00%
-12.81M
209.92%
-1.45B
11,204.62%
net change in cash
9.97B
-
-22.08B
321.48%
2.13B
109.63%
2.76B
29.65%
-5.18B
287.75%
2.00B
138.60%
13.73B
587.10%
-721.24M
105.25%
-12.01B
1,564.51%
-2.09B
82.60%
-997.32M
52.25%
cash at beginning of period
13.39B
-
23.36B
74.42%
1.28B
94.50%
3.41B
165.57%
6.17B
80.83%
991.23M
83.93%
2.99B
201.58%
16.72B
459.27%
16.00B
4.31%
3.99B
75.05%
1.90B
52.32%
cash at end of period
23.36B
-
1.28B
94.50%
3.41B
165.57%
6.17B
80.83%
991.23M
83.93%
2.99B
201.58%
16.72B
459.27%
16.00B
4.31%
3.99B
75.05%
1.90B
52.32%
906.14M
52.40%
operating cash flow
-3.99B
-
-11.92B
198.82%
2.92B
124.49%
5.63B
92.96%
3.79B
32.71%
-2.62B
169.14%
10.59B
503.96%
7.77B
26.59%
1.42B
81.78%
4.15B
193.18%
4.20B
1.02%
capital expenditure
-1.88B
-
-5.78B
207.31%
-2.54B
56.15%
-4.45B
75.57%
-43.34B
873.37%
-3.92B
90.96%
-14.48B
269.78%
-17.21B
18.85%
-33.09B
92.26%
-48.66B
47.04%
-24.39B
49.87%
free cash flow
-5.87B
-
-17.71B
201.54%
383.94M
102.17%
1.18B
207.81%
-39.55B
3,446.41%
-6.54B
83.47%
-3.89B
40.49%
-9.44B
142.55%
-31.67B
235.66%
-44.50B
40.50%
-20.19B
54.62%

All numbers in (except ratios and percentages)